BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 36265309)

  • 1. The role of SARS-CoV-2 accessory proteins in immune evasion.
    Zandi M; Shafaati M; Kalantar-Neyestanaki D; Pourghadamyari H; Fani M; Soltani S; Kaleji H; Abbasi S
    Biomed Pharmacother; 2022 Dec; 156():113889. PubMed ID: 36265309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.
    Redondo N; Zaldívar-López S; Garrido JJ; Montoya M
    Front Immunol; 2021; 12():708264. PubMed ID: 34305949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
    Hassan SS; Choudhury PP; Dayhoff GW; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Pizzol D; Adadi P; Lal A; Soares A; Mohamed Abd El-Aziz T; Brufsky AM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Ã; Chauhan G; Palu G; Mishra YK; Barh D; Santana Silva RJ; Andrade BS; Azevedo V; Góes-Neto A; Bazan NG; Redwan EM; Tambuwala M; Uversky VN
    Arch Biochem Biophys; 2022 Mar; 717():109124. PubMed ID: 35085577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target genes used for biosensor development in COVID-19 diagnosis.
    Zandi M; Fani M
    Biosens Bioelectron; 2022 Mar; 200():113924. PubMed ID: 34974265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
    Shemesh M; Aktepe TE; Deerain JM; McAuley JL; Audsley MD; David CT; Purcell DFJ; Urin V; Hartmann R; Moseley GW; Mackenzie JM; Schreiber G; Harari D
    PLoS Pathog; 2021 Aug; 17(8):e1009800. PubMed ID: 34437657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron variant BA.2 with deletion of ORF7a, ORF7b and ORF8.
    Tang Z; Yu P; Guo Q; Chen M; Lei Y; Zhou L; Mai W; Chen L; Deng M; Kong W; Niu C; Xiong X; Li W; Chen C; Lai C; Wang Q; Li B; Ji T
    Virol J; 2023 May; 20(1):106. PubMed ID: 37248496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
    Zhang J; Li Q; Cruz Cosme RS; Gerzanich V; Tang Q; Simard JM; Zhao RY
    mBio; 2021 Feb; 13(1):e0016922. PubMed ID: 35164548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission.
    Ye C; Park JG; Chiem K; Dravid P; Allué-Guardia A; Garcia-Vilanova A; Pino Tamayo P; Shivanna V; Kapoor A; Walter MR; Kobie JJ; Plemper RK; Torrelles JB; Martinez-Sobrido L
    Microbiol Spectr; 2023 Jun; 11(3):e0065323. PubMed ID: 37191507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles and functions of SARS-CoV-2 proteins in host immune evasion.
    Rashid F; Xie Z; Suleman M; Shah A; Khan S; Luo S
    Front Immunol; 2022; 13():940756. PubMed ID: 36003396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Accessory Protein ORF7b Mediates Tumor Necrosis Factor-α-Induced Apoptosis in Cells.
    Yang R; Zhao Q; Rao J; Zeng F; Yuan S; Ji M; Sun X; Li J; Yang J; Cui J; Jin Z; Liu L; Liu Z
    Front Microbiol; 2021; 12():654709. PubMed ID: 34484133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion.
    Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.
    Li JY; Liao CH; Wang Q; Tan YJ; Luo R; Qiu Y; Ge XY
    Virus Res; 2020 Sep; 286():198074. PubMed ID: 32589897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
    Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
    mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of autophagy by SARS-CoV-2 proteins.
    Koepke L; Hirschenberger M; Hayn M; Kirchhoff F; Sparrer KM
    Autophagy; 2021 Sep; 17(9):2659-2661. PubMed ID: 34281462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities.
    Hayn M; Hirschenberger M; Koepke L; Nchioua R; Straub JH; Klute S; Hunszinger V; Zech F; Prelli Bozzo C; Aftab W; Christensen MH; Conzelmann C; Müller JA; Srinivasachar Badarinarayan S; Stürzel CM; Forne I; Stenger S; Conzelmann KK; Münch J; Schmidt FI; Sauter D; Imhof A; Kirchhoff F; Sparrer KMJ
    Cell Rep; 2021 May; 35(7):109126. PubMed ID: 33974846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of SARS-CoV-2 accessory proteins in immunopathogenesis.
    Ito H; Tamura T; Wang L; Mori K; Tsuda M; Suzuki R; Suzuki S; Yoshimatsu K; Tanaka S; Fukuhara T
    Microbiol Immunol; 2024 Jun; ():. PubMed ID: 38837257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion.
    Neches RY; Kyrpides NC; Ouzounis CA
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 ORF3a inhibits cGAS-STING-mediated autophagy flux and antiviral function.
    Su J; Shen S; Hu Y; Chen S; Cheng L; Cai Y; Wei W; Wang Y; Rui Y; Yu XF
    J Med Virol; 2023 Jan; 95(1):e28175. PubMed ID: 36163413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.